glp 1 negative reviews GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis I TRIED A GLP-1 FOR

Vial Size: 10ML Suggested Dosing: Inject .50 ML Intramuscularly, twice a week

A prospective, placebo-controlled, randomized study (NCT00940602) found that DFX significantly reduced the combined risk of hospitalization for worsening heart function or congestive heart failure in MDS patients, but had no significant effect on left ventricular ejection fraction or pulmonary artery pressure

Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C

Haykal D, Hersant B, Cartier H, Meningaud JP

Serving Los Angeles and virtual patients across California

high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnea, heart disease, knee osteoarthritis, asthma, chronic obstructive pulmonary disease, non-alcoholic fatty liver disease, polycystic ovarian syndrome, or coronary artery disease)